Head and neck squamous cell carcinoma

The Molecular Basis of Cancer

Volumn , Issue , 2008, Pages 479-485

  Fury, Matthew G ^a   Pfister, David G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051765119     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603703-3.10038-X     Document Type: Chapter

References (58)

1. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2006. CA Cancer J Clin 2007, 56:106.
2. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988, 48:3282.
3. Slaughter DP, Southwick HW, Smejkal W "Field cancerization" in oral stratified squamous epithelium; clinical impications of multicentric origin. Cancer 1953, 6:963.
4. Fakhry C, Gillison ML Clinical implications of human papillomaviruses in head and neck cancers. J Clin Oncol 2006, 24:2606.
5. Yu MC, Yuan J-M Epidemiology of nasopharynx carcinoma. Sem Cancer Biol 2002, 12:421.
6. Greene FL, Page DL, Fleming ID, et al. AJCC (American Joint Committee on Cancer) Cancer Staging Manual 2002, Springer-Verlag, New York. 6th ed.
7. Gollin SM Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 2001, 23:238.
8. Perez-Ordonez B, Beauchemin M, Jordan RCK Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006, 59:445.
9. Sporn MB, Dunlop NM, Newton DL, Smith JM Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976, 35:1332.
10. Lotan R, Xu X-C, Lippman SM, et al. Suppression of retinoic acid receptor-beta in premalignant lesions and its up-regulation by isoretinoin. N Engl J Med 1995, 332:1405.
11. Boyle JO, Langenfeld J, Lonardo F, et al. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed bronchial epithelial cells. J Natl Cancer Inst 1999, 91:373.
12. Khuri FR, Lee JJ, Lippman SM, et al. Randomized phase III trial of low-dose isoretinoin for prevention of second primary cancers in stage I and II head and neck cancer patients. J Natl Cancer Inst 2006, 98:441.
13. Moraitis D, Du B, De Lorenzo MS, et al. Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for a role of epidermal growth factor receptor and its ligands. Cancer Res 2005, 65:664.
14. Rubin Grandis J, Melhem MF, Barnes EL, Tweardy D Quantitative immunohistochemical analysis of transforming growth factor alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996, 78:1284.
15. Ang KK, Andratschke NH, Milas L Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiation Oncology Biol Phys 2004, 58:959.
16. Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, Eccles SA Biological significance of c- erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 2005, 24:47.
17. Lee JW, Soung YH, Kim SW, et al. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res 2005, 11:2879.
18. Loeffler-Ragg J, Witsch-Baumgartner M, Tzankov A, et al. Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma. Eur J Cancer 2006, 42:109.
19. Qiu W, Schonleben F, Li X, et al. PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res 2006, 12:1441.
20. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A Overexpression of cyclin D1 correlates with recurrence in a group of 47 operable squamous cell carcinomas of the head and neck. Cancer Res 1995, 55:975.
21. Xi S, Zhang Q, Dyer KF, et al. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem 2003, 278:31574-31583.
22. Xi S, Gooding WE, Grandis JR In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene 2005, 24:970.
23. Masuda M, Suzui M, Yasumatu R, et al. Constitutive activation of signal transducers and activators of transcription 3 (STAT3) correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 2002, 62:3351.
24. Yeatman TJ A renaissance for SRC. Nat Rev Cancer 2004, 4:470.
25. Zhang Q, Thomas SM, Xi S, et al. Src family kinases mediate epidermal growth factor receptor cleavage, proliferation, and invasion in head and neck cancer cells. Cancer Res 2004, 64:6166.
26. Johnson FM, Saigal B, Talpaz M, Donato NJ Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Clin Cancer Res 2005, 11:6924.
27. Sato K, Sato A, Aoto M, Fukami Y Site-specific association of c-SRC with epidermal growth factor receptor in A431 cells. Biochem Biophys Res Commun 1995, 210:844.
28. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995, 332:712.
29. Osman I, Sherman E, Singh B, et al. Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol 2002, 20:2980.
30. Bradford CR, Zhu S, Wolf GT, et al. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Otolaryngol Head Neck Surg 1995, 113:408.
31. Koch WM, Brennan JA, Zahurak M, et al. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996, 88:1580.
32. Cabelguenne A, Blons H, de Waziers I, et al. p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. J Clin Oncol 2000, 18:1465.
33. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Engl J Med 1995, 332:429.
34. Bradford CR, Zhu S, Poore J, et al. p53 mutation as a prognostic marker in advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Cooperative Study Group. Arch Otolaryngol Head Neck Surg 1997, 123:605.
35. Nemunaitis J, Ganly I, Khuri F, et al. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res 2000, 60:6359.
36. Khuri F, Nemunaitis J, Ganly I, et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000, 6:879.
37. Garber K China approves the world's first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst 2006, 98:298.
38. INK4a expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999, 5:2810.
39. ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Clin Cancer Res 2005, 11:4107.
40. Lee JI, Soria J-C, Hassan KA, et al. Loss of PTEN expression as a prognostic marker in tongue cancer. Arch Otolaryngol Head Neck Surg 2001, 127:1441.
41. Jones J, Sugiyama M, Watt FM, Speight PM Integrin expression in normal, hyperplastic, dysplastic and malignant oral epithelium. J Patho 1993, 169:235.
42. Mercurio AM, Rabinovitz I, Shaw LM The alpha(6)beta(4) integrin and epithelial cell migration. Curr Opin Cell Biol 2001, 13:541.
43. Ferrara N Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004, 25:581.
44. Kyzas PA, Cunha IW, Ionnidis JPA Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clin Cancer Res 2005, 11:1434.
45. Franchi A, Massi D, Santucci M, et al. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J Pathol 2006, 208:439.
46. Szentirmay Z, Polus K, Tamas L, et al. Human papillomavirus in head and neck cancer: molecular biology and clinicopathologic correlations. Cancer Metastasis Rev 2005, 24:19.
47. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709.
48. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRB cell cycle control. Oncogene 2002, 21:1510.
49. INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003, 107:394.
50. Balz V, Scheckenbach K, Gotte K, Bockmuhl U, Petersen I, Bier H Is the p53 inactivation frequency in squamous cell carcinomas of the head and underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res 2003, 63:1188.
51. Haraf DJ, Nodzenski E, Brachman D, et al. Human papillomavirus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996, 2:755.
52. Chiba I, Shindoh M, Yasuda M, et al. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 1996, 12:1663.
53. Kreimer AR, Clifford GM, Boyle P, Francheschi S Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14:467.
54. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM Human papillomavirus infection and survival in oral squamous cell cancer. Otolaryngol Head Neck Surg 2001, 125:1.
55. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995, 333:693.
56. Brooks L, Yao QY, Rickinson AB, Young LS Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992, 66:2689.
57. Lin J-C, Wang W-Y, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004, 350:2461.
58. Roepman P, Wessels LFA, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005, 37:182.